Drugmaker Valeant close to buying Salix – source

NEW YORK (Reuters) – Valeant Pharmaceuticals International Inc is close to a $10.2 billion deal to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd, according to a person directly familiar with the matter.




Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

one + two =